Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/07/17 → 30/06/18 |
Funding
- MRC: £94,072.00
Developing SFXN3-targeted therapies to prevent neurodegeneration
- Gillingwater, Tom (Principal Investigator)
- Wishart, Thomas (Co-investigator)
| Status | Finished |
|---|---|
| Effective start/end date | 1/07/17 → 30/06/18 |